glp 1 facts GLP-1 Safety Check Key Facts GPs Should Know

However, the use time and effect of GLP-1RAs, and the adverse reactions after long-term use must also be fully paid attention to and studied before clinical application

39:1115-1122 [PubMed: 27289124] 183

Clinicians should inquire about baseline activity levels, including strength training

This not only indicates that oral semaglutide has similar efficacy in the treatment of obesity compared to the injectable form but also that its oral route of administration may help overcome psychological barriers to injection therapy for some patients, thus improving compliance and acceptance

Staying informed about dosing updates and FDA actions remains essential in this dynamic GLP-1/GIP landscape